Filtyp
Projects start with a meeting between the researcher and LBIC staff representing the platform requested. The main goal of this first meeting is to inform each other on the preclinical imaging possibilities available (LBIC) and to identify the scientific questions and needs of the project (researcher). Publications provided by the researcher will be used to establish the strategy of the project. In
The project costs are calculated taking external (outside LU) as well as internal grants for equipment and staff into consideration. LBIC as a core facility is dependent on external as well as internal funding. In order to keep our machine park well maintained and our research output at the cutting edge we must implement user fees. These fees are predominantly used for maintenance and service cont
All projects performed on LBIC´s preclinical imaging platforms are evaluated before acceptance with respect to possibility to perform the intended experiments successfully, given the available equipment at LBIC. This evaluation is performed by the LBIC preclinical research board (RB). Please note that in the application the intended experiments should be described in their biological or medical co
LBIC has a limited staff (for staff researchers and other staff members, see homepage). LBIC staff will to the best of their ability help researchers with their projects, given the complexity of the equipment. At present, however, LBIC cannot within its budget provide full service from start to goal for research groups that have received approval for their project.As a general rule, LBIC staff wil
AcknowledgementsIt is the mission of LBIC to “establish and provide a major translational bio-imaging center at Lund university, combining knowledge in the fields of medical physics, preclinical and clinical medicine, chemistry, technology and applied mathematics in order to develop imaging methods for the advanced study of human morphology, cellular metabolism and physiological function in health
Regarding ownership of raw data (spectra, animal and sample images etc.) the juridical situation has been discussed with the LU juridical department. One interpretation can be that LBIC possess ownership of such raw data, but the juridical situation is unclear.LBIC´s policy at present is:LBIC (LU) has the right to use raw data as described above, however it is recommended that prior to public use
The Preclinical In Vivo Imaging platform provides advanced non-invasive imaging technologies for preclinical research. The platform combines Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT) and X-ray Computed Tomography (µCT), offering complementary methods for anatomical, functional, metabolic and molecular imaging in vivo. B
https://www.lbic.lu.se/getting-started-lbic/preclinical-vivo-imaging - 2026-07-23
The following policy outlines the principles and procedures governing the use of LBIC's preclinical imaging equipment. It includes the following sections:(A) Project Planning(B) User Fees(C) How to apply for scan time(D) The research board and its decision(E) Support from LBIC staff for approved projects(F) Scientific results(G) Ownership and handling of dataIn accordance with a decision taken at
https://www.lbic.lu.se/lbic-preclinical-user-policy - 2026-07-23
Meet our scientists: Sharpness and depth that moves research forwardAn article about LBIC and Pia Sundgren.Read the article (in Swedish only at the moment, opens in new window)
https://www.lbic.lu.se/news-events - 2026-07-23
Back to TEM embedding
https://www.lbic.lu.se/tem-embedding-1 - 2026-07-23
Back to previous page
https://www.lbic.lu.se/tem-embedding-2 - 2026-07-23
Back to previous page
https://www.lbic.lu.se/tem-embedding-3 - 2026-07-23
Back to previous page
https://www.lbic.lu.se/tem-negative-staining - 2026-07-23
Preclinical and 7T publications 2018Mostajeran M, Wetterling F, Blixt FW, Edvinsson L, Ansar S. Acute mitogen-activated protein kinase 1/2 inhibition improves functional recovery and vascular changes after ischaemic stroke in rat-monitored by 9.4 T magnetic resonance imaging. Acta Physiol (Oxf). 2018 May; 223(1):e12985, doi: 10.1111/apha.12985Sanchez-Heredia JD, Avendal J, Bibic A, Lau BK. Radiati
To discuss your project or gain access to our facilities, please contact the relevant platform representative.Preclinical User PolicyThe following policy outlines the principles and procedures governing the use of LBIC's preclinical imaging equipment:LBIC Preclinical User PolicyAcknowledgementPublications containing data generated using equipment or services provided by the Lund University Bioimag
https://www.lbic.lu.se/getting-started-lbic/general-information - 2026-07-23
Dummy page
https://www.lbic.lu.se/dummy-page - 2026-07-23
Lund University Bioimaging Centre (LBIC) is Lund University’s central infrastructure for advanced bioimaging and translational imaging research within the Faculty of Medicine. Established in 2008, LBIC provides researchers with access to state-of-the-art imaging technologies and multidisciplinary expertise spanning biological scales from molecules and cells to whole organisms and humans.LBIC is cu
https://www.lbic.lu.se/about-lbic - 2026-07-23
Preclinical and 7T publications 2017Wasserstrom S, Morén B, Stenkula KG. Total Internal Reflection Fluorescence Microscopy to Study GLUT4 Trafficking. Methods Mol Biol. (2018) 1713:151-159. Published online 08 December 2017.Horstmann P.F., Raina D.B. , Isaksson H., Hettwer W., Lidgren L., PetersenM.M., Tägil M. Composite Biomaterial as a Carrier for Bone-Active Substances for Metaphyseal Tibial Bo
Preclinical and 7T publications 2016Gottschalk M, Troprès I, Lamalle L, Grand S, Le Bas JF, Segebarth C. Refined modelling of the short-T2 signal component and ensuing detection of glutamate and glutamine in short-TE, localised, (1) H MR spectra of human glioma measured at 3 T. NMR Biomed. 2016 Jul;29(7):943-51. doi: 10.1002/nbm.3548Hansen JS, Krintel C, Hernebring M, Haataja TJK, de Marèa S, Wass
Preclinical and 7T publications 2015Erlandsson L, Nääv Å, Hennessy A, Vaiman D, Gram M, Åkerström B, Hansson SR. Inventory of Novel Animal Models Addressing Etiology of Preeclampsia in the Development of New Therapeutic/Intervention Opportunities. Am J Reprod Immunol. 2016 Mar;75(3):402-10. doi: 10.1111/aji.12460. Epub 2015 Dec 18.Ahlstedt J., Tran T.A., Strand S-E, Gram M., Åkerström B. Human Ant
